This commentary describes limitations of mental health parity requirements in ensuring access to insurance coverage for mental health treatment and surveys regulatory options employed by states in Medicaid managed care programs as supplements to parity that can further reduce the risk of inappropriate denials of coverage.
Get full access to this article
View all access options for this article.
References
1.
E.g. U.S. Dep’t of Health and Human Servs., Office of the Surgeon General, “Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health,”Rockville, MD, 2016.
2.
S.A.Tovino, “All Illnesses Are (Not) Created Equal: Reforming Federal Mental Health Insurance Law,”Harvard Journal on Legislation49, no. 1 (2011): 1-51, at 27-31 (describing societal harms connected to untreated mental illness).
3.
E.g. Government Accountability Office, “Opioid Use Disorder: Barriers to Medicaid Beneficiaries’ Access to Treatment Medications,”Washington, DC, GAO-20-233, 2020 (describing prior authorization requirements and limitations on distribution as creating barriers to Medication Assisted Treatment).
4.
SeeM.B.Lawrence, “The Social Consequences Problem in Health Insurance and How to Solve It,”Harvard Law & Policy Review13, no. 2 (2019): 593-660.
5.
See supra note 3.
6.
B.D.Heller, “Revolutionizing the Mental Health Parity and Addiction Equity Act of 2008,”Seton Hall Law Review47 (2017): 569-602 (calling for “true parity”).
7.
S.A.Tovino, “Reforming State Mental Health Parity Law,”Houston Journal of Health Law & Policy11 (2011): 455-504, at 457.
8.
Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, Pub. L. No. 100-343 § § 511-12, 122 Stat. 365 (codified at 29 U.S.C. § 1185a & 42 U.S.C. § 300gg-26 (2012)).
9.
See sources cited supra note 6.
10.
M.J.B.Lawrence, “Regulatory Pathways to Promote Treatment for Substance Use Disorder,”Journal of Law, Medicine & Ethics46, no. 4 (2018): 935-938.
11.
M.A.Fineman, “Beyond Identities: The Limits of an Antidiscrimination Approach to Equality,”Boston University Law Review92, no. 6 (2012): 1713-1770, at 1737.
12.
T.Baker, “Health Insurance, Risk, and Responsibility after the Patient Protection and Affordable Care Act,”University of Pennsylvania Law Review159, no. 6 (2011): 1577.
13.
M.Galanter, “Why the ‘Haves’ Come Out Ahead: Speculations on the Limits of Legal Change,”Law & Society Review9, no. 1 (1974): 95-160.
14.
J.P.Hall, T.A.LaPierre, and N.K.Kurth, “Medicaid Managed Care: Issues for Enrollees With Serious Mental Illness,”American Journal of Managed Care25, no. 9 (2019): 450-456.
15.
SeeM.B.Lawrence, “The Social Consequences Problem in Health Insurance and How to Solve It,”Harvard Law & Policy Review13, no. 2 (2019): 593-660.
16.
SeeR.G.Frank, “Reflections on the Mental Health Parity and Addiction Equity Act After 10 Years,”Milbank Quarterly96, no. 4 (2018): 615-618.
17.
For a survey of four states’ approaches to complementing parity in the employer insurance marketplace, seeR.Kingshill, “Finding Parity Through Preclusion: Novel Mental Health Parity Solutions at the State Level,”Dickenson Law Review (2020) (forthcoming).
18.
Medicaid and CHIP Payment and Access Commission, “Medicaid Enrollment Changes Following the ACA,”available at <https://www.macpac.gov/subtopic/medicaid-enrollment-changes-following-the-aca/> (last visited August 3, 2020); Center for Health Care Strategies, Developing Capitation Rates for Medicaid Managed Long-Term Services and Supports Programs: State Considerations, Technical Assistance Brief (January 2016).
19.
T.Douglas, “Medicaid Waivers and Consumer Protection: Evidence from the States,”Annals of Health Law and Life Sciences28, no. 2 (2019): 101-134, 114 (describing failure of Managed Care oversight in Texas).)
20.
Virginia.gov, “Virginia Regulatory Town Hall,”available at <http://townhall.virginia.gov/L/ViewXML.cfm?textid=11792> (last visited August 4, 2020); W. Va. Code § 33-25A-8n (2019) (requiring coverage for abuse-deterrent opioids).
21.
C.Juhnkeet al., “A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare Systems,”International Journal of Integrated Care16, no. 4 (2016): 4.
22.
I. D.Buck, “Managing Medicaid,”St. Louis University Jourtnal of Health Law & Policy11, no. 1 (2017): 118-122 (discussing risk adjustment and risk sharing techniques in Medicaid managed care).
23.
M.Lawrence, “Regulatory Pathways to Promote Treatment for Substance Use Disorder,”Journal of Law, Medicine & Ethics46, no. 4 (2018): 935-938.
24.
T. J.Layton, T. G.McGuire, and R. C.van Kleef, Deriving Risk Adjustment Payment Weights to Maximize Efficiency of Health Insurance Markets, at 4 (NBER 2016).
25.
T. G.McGuire, R. C.van Kleef, S. H. C.van Veen, “Paying for Mental Health Care in Private Health Insurance in the Netherlands: Some Lessons for the United States,”Psychiatry Online, at 1-2 (April15, 2020), available at <https://ps.psychiatryonline.org/doi/pdf/10.1176/appi.ps.202000104> (last visited August 28, 2020).
26.
S.L.Worthyet al., “Now or Never: The Urgent Need for Action Against Unfair Coverage Denials for Quality Health Care,”Loyola University Chicago Law Journal48, no. 4 (2017): 1042-1097 (identifying types of claims that can be brought in court for unfair coverage denials).
K.T.Vukadin, “Hope or Hype?: Why The Affordable Care Act’s New External Review Rules for Denied ERISA Healthcare Claims Needs More Reform,”Buffalo Law Review60, no. 5 (2012):1201-1253.
29.
West Virginia Department of Health and Human Services, West Virginia Medicaid Mountain Health Trust Annual Report, State Fiscal Year 2017 (2017) (describing at-will reporting of various metrics).
